Project Title: |
Anti Factor A antibody aHUS treated with complement blocking theraphy only |
Project Type: |
Observational Study, Enrolment ongoing Adjunct biobank: Serum, Plasma |
Disease group(s): |
Thrombotic microangiopathies |
Project Summary: |
Anti Factor A antibody aHUS patients treated with complement blocking therapy only, no plasma Exchange no immunossupressant medication. Outcome at 12 months. 6 patients enrolled |
Lead principal investigator(s): |
Adrian Catalin Lungu, Bucharest |
Co-investigator(s): |
Anca Marin, Bucharest |
Project Period: |
01/2025 - 12/2025 |
Sponsors: |
Non-profit foundation |